Mutations in the gene for the transcription factor hepatocyte nuclear factor (HNF) 1alpha cause maturity-onset diabetes of the young (MODY) 3, a form of diabetes that results from defects in insulin secretion. Since the nature of these defects has not been defined, we compared insulin secretory function in heterozygous [HNF-1alpha (+/-)] or homozygous [HNF-1alpha (-/-)] mice with null mutations in the HNF-1alpha gene with their wild-type littermates [HNF-1alpha (+/+)]. Blood glucose concentrations were similar in HNF-1alpha (+/+) and (+/-) mice (7.8+/-0.2 and 7.9+/-0.3 mM), but were significantly higher in the HNF-1alpha (-/-) mice (13.1+/-0.7 mM, P < 0.001). Insulin secretory responses to glucose and arginine in the perfused pancreas and perifused islets from HNF-1alpha (-/-) mice were < 15% of the values in the other two groups and were associated with similar reductions in intracellular Ca2+ responses. These defects were not due to a decrease in glucokinase or insulin gene transcription. beta cell mass adjusted for body weight was not reduced in the (-/-) animals, although pancreatic insulin content adjusted for pancreas weight was slightly lower (0.06+/-0.01 vs. 0.10+/-0.01 microg/mg, P < 0.01) than in the (+/+) animals. In summary, a null mutation in the HNF-1alpha gene in homozygous mice leads to diabetes due to alterations in the pathways that regulate beta cell responses to secretagogues including glucose and arginine. These results provide further evidence in support of a key role for HNF-1alpha in the maintenance of normal beta cell function.
M Pontoglio, S Sreenan, M Roe, W Pugh, D Ostrega, A Doyen, A J Pick, A Baldwin, G Velho, P Froguel, M Levisetti, S Bonner-Weir, G I Bell, M Yaniv, K S Polonsky
Title and authors | Publication | Year |
---|---|---|
Hepatic deletion of SIRT1 decreases hepatocyte nuclear factor 1α/farnesoid X receptor signaling and induces formation of cholesterol gallstones in mice
A Purushotham, Q Xu, J Lu, JF Foley, X Yan, DH Kim, JK Kemper, X Li |
Molecular and cellular biology | 2012 |
Research Resource: The Pdx1 Cistrome of Pancreatic Islets
C Khoo, J Yang, SA Weinrott, KH Kaestner, A Naji, J Schug, DA Stoffers |
Molecular Endocrinology | 2012 |
Serum levels of pancreatic stone protein (PSP)/reg1A as an indicator of beta-cell apoptosis suggest an increased apoptosis rate in hepatocyte nuclear factor 1 alpha (HNF1A-MODY) carriers from the third decade of life onward
S Bacon, MP Kyithar, J Schmid, SR Rizvi, C Bonner, R Graf, JH Prehn, MM Byrne |
BMC Endocrine Disorders | 2012 |
Clinical features and treatment of maturity onset diabetes of the young (MODY)
DS Gardner, ES Tai |
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2012 |
Identification of hepatocyte growth factor activator (Hgfac) gene as a target of HNF1α in mouse β-cells
T Ohki, Y Sato, T Yoshizawa, K Yamamura, K Yamada, K Yamagata |
Biochemical and Biophysical Research Communications | 2012 |
Molecular cloning and characterization of the anti-obesity gene adipose in pig
Y Wu, Q Long, B Feng, X Zhu, Z Zheng, S Gao, M Gao, L Gan, L Zhou, Z Yang |
Gene | 2012 |
Mitochondrial dysfunction in pancreatic β cells
S Supale, N Li, T Brun, P Maechler |
Trends in Endocrinology & Metabolism | 2012 |
Inhibition of hepatocyte nuclear factor 1 and 4 alpha (HNF1α and HNF4α) as a mechanism of arsenic carcinogenesis
A Pastoret, R Marcos, A Sampayo-Reyes, O Saucedo-Cardenas, GH Lozano-Garza, A Hernandez |
Archives of Toxicology | 2012 |
Developmental Origins of Type 2 Diabetes in Aboriginal Youth in Canada: It Is More Than Diet and Exercise
K Millar, HJ Dean |
Journal of nutrition and metabolism | 2012 |